- Home
- KALV vs RNGR Comparison
KALV vs RNGR Comparison
Compare KALV & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- RNGR
- Stock Information
- Founded
- KALV N/A
- RNGR 2017
- Country
- KALV United States
- RNGR United States
- Employees
- KALV N/A
- RNGR N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- RNGR Oilfield Services/Equipment
- Sector
- KALV Health Care
- RNGR Energy
- Exchange
- KALV Nasdaq
- RNGR Nasdaq
- Market Cap
- KALV 362.2M
- RNGR 388.4M
- IPO Year
- KALV N/A
- RNGR 2017
- Fundamental
- Price
- KALV $10.03
- RNGR $17.42
- Analyst Decision
- KALV Strong Buy
- RNGR Hold
- Analyst Count
- KALV 8
- RNGR 2
- Target Price
- KALV $25.67
- RNGR $12.50
- AVG Volume (30 Days)
- KALV 321.8K
- RNGR 90.0K
- Earning Date
- KALV 03-10-2025
- RNGR 03-03-2025
- Dividend Yield
- KALV N/A
- RNGR 1.15%
- EPS Growth
- KALV N/A
- RNGR N/A
- EPS
- KALV N/A
- RNGR 0.63
- Revenue
- KALV N/A
- RNGR $579,500,000.00
- Revenue This Year
- KALV N/A
- RNGR N/A
- Revenue Next Year
- KALV N/A
- RNGR $12.00
- P/E Ratio
- KALV N/A
- RNGR $27.67
- Revenue Growth
- KALV N/A
- RNGR N/A
- 52 Week Low
- KALV $7.30
- RNGR $9.27
- 52 Week High
- KALV $15.50
- RNGR $18.45
- Technical
- Relative Strength Index (RSI)
- KALV 59.09
- RNGR 54.07
- Support Level
- KALV $8.99
- RNGR $17.08
- Resistance Level
- KALV $11.00
- RNGR $18.45
- Average True Range (ATR)
- KALV 0.57
- RNGR 0.52
- MACD
- KALV 0.11
- RNGR 0.02
- Stochastic Oscillator
- KALV 57.08
- RNGR 58.52
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions and Ancillary Services, of which key revenue is derived from High Specification Rigs segment.